Beloranib
bestPWS
Zafgen · Phase 3 · Terminated · Enrollment 108
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | Obesity or overweight | n/r | 28 | n/r | n/r |
| ZGN-440 Injectable Suspension (1.8 mg) | Obesity or overweight | 1.8 mg | 28 | n/r | n/r |
| ZGN-440 Injectable Suspension (2.4 mg) | Obesity or overweight | 2.4 mg | 28 | n/r | n/r |